Reuters logo
BRIEF-GSK, Biological E in JV to develop vaccine for India, other developing countries
January 28, 2013 / 9:06 AM / 5 years ago

BRIEF-GSK, Biological E in JV to develop vaccine for India, other developing countries

LONDON, Jan 28 (Reuters) - GlaxoSmithKline Plc : * Gsk and biological e. announce joint venture to develop combination vaccine

for India and other developing countries * Jv will bear development costs for candidate vaccine expected to enter phase

1 development in next 2 years

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below